First human test for new biotech drug begins
NCT ID NCT06650761
Summary
This is a very early study to check if a new drug called CDX-622 is safe for people. It will be tested in 85 healthy volunteers who do not have the conditions the drug is meant to treat. Researchers will give different doses to see how the body handles the drug and watch for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celerion, Inc.
Tempe, Arizona, 85283, United States
Conditions
Explore the condition pages connected to this study.